EPISODE 120: SPECIAL PANEL - EDWARD DOWD, KELLY BROWN & JESSICA ROSE

We’ve reached a tipping point in evaluating the Covid-19 vaccines as still more studies indicate it is time to be worried - the efficacy is crashing and adverse reactions are gaining credibility. Also — excess death numbers began climbing when the jabs were mandated and although no one can make a direct link — the time has come to evaluate a possible connection. Trish speaks to a special panel — including former hedge fund manager Edward Dowd and investor Kelly Brown who both say the numbers are a significant, and independent researcher Jessica Rose who has been deep diving into the adverse reaction data.